Cargando…
Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1
Despite recent advances in the detection and treatment of breast cancer, many shortcomings remain, providing incentives to search for new therapeutic targets. This review provides information on the expression and actions of dopamine receptor-1 (D1R) in breast cancer. D1R is overexpressed in a signi...
Autores principales: | Ben-Jonathan, Nira, Borcherding, Dana C., Fox, Sejal, Hugo, Eric R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019214/ https://www.ncbi.nlm.nih.gov/pubmed/35582277 http://dx.doi.org/10.20517/cdr.2019.83 |
Ejemplares similares
-
cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013) -
Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017) -
Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
por: Borcherding, Dana C., et al.
Publicado: (2021) -
cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009) -
Dopamine Receptors in Human Adipocytes: Expression and Functions
por: Borcherding, Dana C., et al.
Publicado: (2011)